A few selected segments from a 6-minute animation created for a first-in-class B-cell maturation antigen (BCMA)-directed personalized immunotherapy called chimeric antigen receptor (CAR) T-cell therapy.

In this CAR T therapy, the T cells are engineered to target a protein called BCMA, which is found in abundance on multiple myeloma cells, but is absent from nearly all normal cells.

View animation >>

Tagged: (CAR) T-cell therapy, antigens, biology, biotechnology, cancer, cancer research, cancer treatment, CAR T, CAR T cell animation, CAR T therapy, CAR T-cell animation, car-t cell therapy, chimeric antigen receptor, chimeric antigen receptor animation, gene therapy, hybrid medical, immune health, immunotherapy, medical animation, Medical science, medical visualisation, pharma, scientific animation, T cells, visual science